Distribution of xenotropic murine leukemia virus-related virus (XMRV) infection in chronic fatigue syndrome and prostate cancer.
Mikovits, Judy A, Huang, Ying, Pfost, Max A et al. · AIDS reviews · 2010
Quick Summary
Researchers tested blood samples from ME/CFS patients for a virus called XMRV using different detection methods. They found that simple DNA tests alone missed infections that were caught by more sensitive techniques. This study explains why different research teams got different results—the testing method matters a lot.
Why It Matters
This work directly addresses the ME/CFS research controversy regarding XMRV detection and highlights that disagreement between studies may reflect technical differences rather than biological disagreement. Understanding proper detection methods is critical for establishing whether XMRV plays a role in ME/CFS pathogenesis. The findings underscore the importance of methodological rigor when investigating potential infectious agents in ME/CFS.
Observed Findings
85% of 101 ME/CFS patients tested positive for XMRV using multiple complementary methods (PCR, sequencing, immunoblotting, viral culture, and serology).
Seven subsequent studies using only DNA PCR on blood products reported failure to detect XMRV in ME/CFS or prostate cancer patients.
When blood samples that tested negative by DNA PCR alone were analyzed using more sensitive methods, XMRV infection was detected, indicating false-negative results.
XMRV viral loads are typically low in unstimulated peripheral blood cells and plasma, making detection dependent on methodology.
Inferred Conclusions
DNA polymerase chain reaction of unstimulated blood cells is insufficient as a stand-alone assay for XMRV detection.
Biological and molecular amplification methods are more sensitive than direct DNA PCR for identifying XMRV infection.
Multiple independent techniques must be applied in combination to accurately determine XMRV infection status.
Methodological inconsistencies across studies likely explain apparent disagreements about XMRV prevalence in ME/CFS populations.
Remaining Questions
What is the true prevalence of XMRV infection in ME/CFS patients when standardized detection protocols are used across studies?
What This Study Does Not Prove
This study does not prove that XMRV causes ME/CFS, only that detection methodology significantly affects reported prevalence rates. It does not resolve whether XMRV is truly present in ME/CFS populations, since subsequent research would challenge these findings. The review does not provide new clinical data linking XMRV infection to specific ME/CFS symptoms or disease mechanisms.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →